Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.
Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, Francis GA, Genest J, Grégoire J, Grover SA, Gupta M, Hegele RA, Lau D, Leiter LA, Leung AA, Lonn E, Mancini GBJ, Manjoo P, McPherson R, Ngui D, Piché ME, Poirier P, Sievenpiper J, Stone J, Ward R, Wray W. Pearson GJ, et al. Among authors: gregoire j. Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26. Can J Cardiol. 2021. PMID: 33781847
Statin therapy and the management of acute coronary syndromes.
Langer A, Constance C, Fodor JG, Frohlich JJ, Grégoire J, Lau DC, Leiter LA, Mancini GB, Marr D, McPherson R, O'Neill BJ, Rabkin SW. Langer A, et al. Among authors: gregoire j. Can J Cardiol. 2003 Jul;19(8):921-7. Can J Cardiol. 2003. PMID: 12876613 Review.
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.
Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E. Anderson TJ, et al. Among authors: gregoire j. Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032. Can J Cardiol. 2013. PMID: 23351925 Review.
Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E. Anderson TJ, et al. Among authors: gregoire j. Can J Cardiol. 2014 Apr;30(4):377-80. doi: 10.1016/j.cjca.2014.01.009. Epub 2014 Jan 17. Can J Cardiol. 2014. PMID: 24589194 No abstract available.
The new dyslipidemia guidelines: what is the debate?
Anderson TJ, Mancini GB, Genest J Jr, Grégoire J, Lonn EM, Hegele RA. Anderson TJ, et al. Among authors: gregoire j. Can J Cardiol. 2015 May;31(5):605-12. doi: 10.1016/j.cjca.2014.11.007. Epub 2014 Nov 11. Can J Cardiol. 2015. PMID: 25816728 Review.
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R. Anderson TJ, et al. Among authors: gregoire j. Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Can J Cardiol. 2016. PMID: 27712954 Review.
The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?
Thanassoulis G, Gregoire J, Pearson GJ. Thanassoulis G, et al. Among authors: gregoire j. Can J Cardiol. 2019 May;35(5):558-563. doi: 10.1016/j.cjca.2019.03.003. Epub 2019 Mar 19. Can J Cardiol. 2019. PMID: 31030858 No abstract available.
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.
Mancini GBJ, O'Meara E, Zieroth S, Bernier M, Cheng AYY, Cherney DZI, Connelly KA, Ezekowitz J, Goldenberg RM, Leiter LA, Nesrallah G, Paty BW, Piché ME, Senior P, Sharma A, Verma S, Woo V, Darras P, Grégoire J, Lonn E, Stone JA, Yale JF, Yeung C, Zimmerman D. Mancini GBJ, et al. Among authors: gregoire j. Can J Cardiol. 2022 Aug;38(8):1153-1167. doi: 10.1016/j.cjca.2022.04.029. Can J Cardiol. 2022. PMID: 35961754
777 results